NewcelX Ltd.
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
NewcelX Ltd. (NCEL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.719x
Based on the latest financial reports, NewcelX Ltd. (NCEL) has a cash flow conversion efficiency ratio of -0.719x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.07 Million) by net assets ($2.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NewcelX Ltd. - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how NewcelX Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
NewcelX Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NewcelX Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VANADIUMCORP RES.
F:NWNA
|
N/A |
|
RAIL3F
SA:RAIL3F
|
N/A |
|
SKELLERUP HLDGS
BE:RZK
|
N/A |
|
RedFlow Limited
PINK:REFXF
|
-0.300x |
|
HIGHL.GL ALLOC.
F:O60
|
N/A |
|
336040
KO:336040
|
N/A |
|
Dae Won Kang Up Co. Ltd.
KQ:000430
|
N/A |
|
LEIFRAS Co., Ltd. American Depositary Shares
NASDAQ:LFS
|
0.011x |
Annual Cash Flow Conversion Efficiency for NewcelX Ltd. (2017–2024)
The table below shows the annual cash flow conversion efficiency of NewcelX Ltd. from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.41 Million | $-4.27 Million | -3.035x | -376.81% |
| 2023-12-31 | $-8.83 Million | $-9.68 Million | 1.096x | +125.92% |
| 2022-12-31 | $3.28 Million | $-13.88 Million | -4.230x | +84.64% |
| 2021-12-31 | $542.39K | $-14.94 Million | -27.538x | -34018.81% |
| 2020-12-31 | $-8.98 Million | $-729.39K | 0.081x | +163.67% |
| 2019-12-31 | $-6.17 Million | $-190.01K | 0.031x | -90.07% |
| 2018-12-31 | $-8.81 Million | $-2.73 Million | 0.310x | -55.95% |
| 2017-12-31 | $-7.72 Million | $-5.43 Million | 0.704x | -- |